Compare BIDU & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIDU | RMD |
|---|---|---|
| Founded | 2000 | 1989 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 33.6B |
| IPO Year | 2005 | 1996 |
| Metric | BIDU | RMD |
|---|---|---|
| Price | $77.71 | $252.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 31 | 20 |
| Target Price | $144.82 | ★ $251.99 |
| AVG Volume (30 Days) | ★ 1.8M | 851.7K |
| Earning Date | 11-17-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | N/A | ★ 9.67 |
| EPS | N/A | ★ 10.43 |
| Revenue | N/A | ★ $2,957,013,000.00 |
| Revenue This Year | N/A | $2.59 |
| Revenue Next Year | $6.19 | $6.92 |
| P/E Ratio | $42.45 | ★ $23.68 |
| Revenue Growth | N/A | ★ 13.44 |
| 52 Week Low | $78.20 | $180.27 |
| 52 Week High | $165.30 | $277.67 |
| Indicator | BIDU | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 27.79 | 76.35 |
| Support Level | N/A | $247.01 |
| Resistance Level | $93.83 | $262.16 |
| Average True Range (ATR) | 1.93 | 5.28 |
| MACD | -0.26 | 2.35 |
| Stochastic Oscillator | 9.41 | 99.03 |
Most of Baidu's revenue comes from Baidu core, with the rest coming from video-streaming subsidiary iQiyi. The firm's main businesses include online marketing services from its search engine, AI cloud infrastructure, AI applications, AI marketing, and autonomous driving.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.